Modelling policy combinations of vaccination and transmission suppression of SARS-CoV-2 in Rio de Janeiro, Brazil
- PMID: 35005325
- PMCID: PMC8719375
- DOI: 10.1016/j.idm.2021.12.007
Modelling policy combinations of vaccination and transmission suppression of SARS-CoV-2 in Rio de Janeiro, Brazil
Abstract
COVID-19 vaccination in Brazil required a phased program, with priorities for age groups, health workers, and vulnerable people. Social distancing and isolation interventions have been essential to mitigate the advance of the pandemic in several countries. We developed a mathematical model capable of capturing the dynamics of the SARS-CoV-2 dissemination aligned with social distancing, isolation measures, and vaccination. Surveillance data from the city of Rio de Janeiro provided a case study to analyze possible scenarios, including non-pharmaceutical interventions and vaccination in the epidemic scenario. Our results demonstrate that the combination of vaccination and policies of transmission suppression potentially lowered the number of hospitalized cases by 380+ and 66+ thousand cases, respectively, compared to an absence of such policies. On top of transmission suppression-only policies, vaccination impacted more than 230+ thousand averted hospitalized cases and 43+ thousand averted deaths. Therefore, health surveillance activities should be maintained along with vaccination planning in scheduled groups until a large vaccinated coverage is reached. Furthermore, this analytical framework enables evaluation of such scenarios.
Keywords: COVID-19; SARS-CoV-2; Vaccination.
© 2022 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Daniel A.M. Villela has a grant for modeling COVID-19 scenarios in Brazil, funded from the National Council for Scientific and Technological Development, a funding agency from the Brazilian federal government. Daniel A.M. Villela is Research Scientist, working for Fiocruz, the biggest research institution in public health in Brazil, which has a vaccine producing unit. All authors declare no financial benefits.
Figures
References
-
- Abbott S., Hellewell J., Munday J., Funk S., nCoV working group C., et al. The transmissibility of novel Coronavirus in the early stages of the 2019-20 outbreak in Wuhan: Exploring initial point-source exposure sizes and durations using scenario analysis. Wellcome Open Research. 2020;5 The Wellcome Trust. - PMC - PubMed
-
- Adeniyi M.O., Oke S.I., Ekum M.I., Benson T., Adewole M.O. Modeling, control and drug development for COVID-19 outbreak prevention. Springer; 2022. Assessing the impact of public compliance on the use of non-pharmaceutical intervention with cost-effectiveness analysis on the transmission dynamics of COVID-19: Insight from mathematical modeling; pp. 579–618.
LinkOut - more resources
Full Text Sources
Miscellaneous
